Biallelic somaticSMARCA4mutations in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)
Pediatric Blood & Cancer2014Vol. 62(4), pp. 728–730
Citations Over TimeTop 22% of 2014 papers
Shivani Bailey, Matthew J. Murray, Leora Witkowski, Elizabeth Hook, Martin Hasselblatt, Robin Crawford, William D. Foulkes, Marc Tischkowitz, James C. Nicholson
Abstract
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare, aggressive tumor that primarily affects young women. SCCOHT has recently been identified as a monogenic disorder caused by germline and/or somatic SMARCA4 mutations. We describe a 15-year-old Caucasian female with a SCCOHT harboring a previously unreported somatic mutation in the SMARCA4 gene (c.1757delA; p.K586.fs) with loss of heterozygosity. No germline mutation was identified. Subsequent immunohistochemical staining confirmed loss of SMARCA4 protein. These molecular findings will aid with SCCOHT diagnosis through immunohistochemical staining for SMARCA4 and in the future may have implications for the management of this disease.
Related Papers
- → Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary)(2016)64 cited
- → Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type(2017)50 cited
- → Biallelic somaticSMARCA4mutations in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)(2014)19 cited
- → Primary rhabdoid tumor of the ovary: When large cells become small cells(2015)7 cited
- [Conduct of the treatment of ovarian tumors; antineoplastic agents in carcinoma of the ovary].(1961)